Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cel Sci Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 85 | 1 | 78 | −6 |
| Shares | 7.67M | 1.50K | 6.46M | −1.21M (−15.7%) |
| Value | $34.5M | $7.00K | $20.0M | −$14.5M (−42.1%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Cel Sci Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 98,300 | $304.0K | 0.01% |
| Plotkin Financial Advisors, LLC | 92,008 | $284.3K | 0.29% |
| Qube Research & Technologies Ltd | 30,181 | $93.0K | 0.00% |
| Hartline Investment Corp | 16,170 | $50.0K | 0.04% |
| Balyasny Asset Management LLC | 15,491 | $48.0K | 0.00% |
| Csenge Advisory Group | 10,700 | $33.0K | 0.00% |
| MML Investors Services, LLC | 10,150 | $31.0K | 0.00% |
| Almanack Investment Partners, LLC. | 4,500 | $16.0K | 0.00% |
| Gables Capital Management Inc. | 800 | $2.00K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 211 | $0 | 0.00% |
Sold out (16)
Institutions that held Cel Sci Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 169,153 | $761.0K |
| Marshall Wace, LLP | 82,752 | $372.0K |
| Cubist Systematic Strategies, LLC | 42,433 | $191.0K |
| Ensign Peak Advisors, Inc | 26,990 | $121.0K |
| Ground Swell Capital, LLC | 22,258 | $100.0K |
| Virtu Financial LLC | 13,638 | $61.0K |
| Redmond Asset Management, LLC | 13,599 | $61.0K |
| Laurion Capital Management LP | 12,633 | $57.0K |
| Tri Locum Partners LP | 11,206 | $50.0K |
| Russell Investments Group, Ltd. | 7,786 | $35.0K |
| Captrust Financial Advisors | 3,955 | $18.0K |
| Aquatic Capital Management LLC | 800 | $4.00K |
| Barclays PLC | 773 | $3.00K |
| New York State Common Retirement Fund | 261 | $1.00K |
| Chilton Capital Management LLC | 5 | $0 |
| Better Money Decisions, LLC | 1 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Cel Sci Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Wealth Management Ltd | 1,500 | $7.00K |